FDAnews
www.fdanews.com/articles/81705-genoway-takes-over-transgenic-commercial-activities-of-ingenko-pty-ltd

GENOWAY TAKES OVER TRANSGENIC COMMERCIAL ACTIVITIES OF INGENKO PTY LTD

October 17, 2005

GenOway, the European market leader in transgenesis, takes over commercial activities for IngenKO Pty Ltd following the Australian company's closure. This confirms genOway's leading position in the market and contributes to the worldwide expansion of the company's activities. IngenKO was set up in June 2001 as a spin-off company of Monash University, a renowned academic institute and a leader in stem cell research. The company gained 4 years experience as a commercial supplier of gene-targeted mice on a service-fee basis to customers in the academic, pharmaceutical, biotechnology and medical research communities in Australia, the USA, Europe, Japan and Asia. IngenKO was one of the major players in this very competitive market.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/4951dd6724a0305a46da578adb192c48.html)